3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Mouth Neoplasms
3
Carcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Recurrence
2
Mycosis Fungoides
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell
2
Laryngeal Neoplasms
2
Vaccinia
1
Sinonasal Squamous Cell Carcinoma
1
Sarcoma
1
Resectable Non-small Cell Lung Cancer
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Immunoblastic Lymphadenopathy
1
Interventions
Carboplatin
13
pembrolizumab
12
Specimen Handling
9
Paclitaxel
5
Magnetic Resonance Spectroscopy
5
Capecitabine
5
Biopsy
5
Nivolumab
4
Cyclophosphamide
4
sacituzumab govitecan
3
Gemcitabine
3
Fulvestrant
3
olaparib
2
fludarabine
2
atezolizumab
2
aldesleukin
2
Taxes
2
Letrozole
2
Epirubicin
2
Docetaxel
2
Cisplatin
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
zimberelimab
1
veliparib
1
trastuzumab deruxtecan
1
toripalimab
1
sintilimab
1
pyrotinib
1
pertuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
cemiplimab
×
30 days
×
Clear all
No trials found.